, Volume 23, Issue 1, pp 3–7 | Cite as

Obstructive sleep apnea and atherosclerosis—update 2019

  • Leonie BienerEmail author
  • Carmen Pizarro
  • Georg Nickenig
  • Dirk Skowasch


Obstructive sleep apnea (OSA) is a common disorder that has been associated with an increased risk of atherosclerosis and its clinical manifestations. While treatment with continuous positive airway pressure (CPAP) has been shown to exert several beneficial effects on cardiovascular disease and prognosis in observational studies, CPAP was not effective in three recent randomized controlled trials unless it was used for more than 4 hours of sleep.


Continuous positive airway pressure Cardiovascular diseases Hypertension Coronary artery disease Risk factors 

Obstruktive Schlafapnoe und Arteriosklerose – Update 2019


Die obstruktive Schlafapnoe (OSA) stellt eine häufige Erkrankung dar, die mit einem erhöhten Risiko für Arteriosklerose und deren klinischen Manifestationen in Zusammenhang gebracht wird. In Beobachtungsstudien wurden zwar für die Behandlung mit kontinuierlichem positivem Atemwegsdruck („continuous positive airway pressure“, CPAP) verschiedene günstige Auswirkungen auf Herz-Kreislauf-Erkrankungen und deren Prognose nachgewiesen, in drei aktuellen randomisierten kontrollierten Studien stellte sich die CPAP-Therapie jedoch nicht als wirksam heraus, wenn sie nicht mindestens vier Stunden lang während des Schlafs eingesetzt wurde.


Kontinuierlicher positiver Atemwegsdruck Kardiovaskuläre Erkrankungen Hypertonie Koronare Herzkrankheit Risikofaktoren 


Compliance with ethical guidelines

Conflict of interest

L. Biener, C. Pizarro, G. Nickenig, and D. Skowasch declare that they have no competing interests.

This article does not contain any studies with human participants or animals performed by any of the authors.


  1. 1.
    WHO (2018) Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016. World Health Organization, GenevaGoogle Scholar
  2. 2.
    WHO (2017) WHO Fact sheet N°317. (Created 05.2017). Accessed 29 Oct 2018Google Scholar
  3. 3.
    Riemann D, Baum E, Cohrs S et al (2017) S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 21(2). CrossRefGoogle Scholar
  4. 4.
    Skowasch D, Bönner G, Nickenig G (2009) Obstruktive Schlafapnoe als Risikofktor der ArterioskleroseGoogle Scholar
  5. 5.
    Maeder MT, Schoch OD, Rickli H (2016) A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease. Vasc Health Risk Manag 12:85–103. CrossRefGoogle Scholar
  6. 6.
    Tuleta I, Pabst S, Juergens UR, Nickenig G, Skowasch D (2011) Obstructive sleep apnoea as a risk factor for atherosclerosis—implication for preventive and personalised treatment. Epma J 2:39–47. CrossRefGoogle Scholar
  7. 7.
    Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. Circulation 118:1080–1111. (In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health))CrossRefGoogle Scholar
  8. 8.
    Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19:2271–2277CrossRefGoogle Scholar
  9. 9.
    Pearse SG, Cowie MR (2016) Sleep-disordered breathing in heart failure. Eur J Heart Fail 18:353–361. CrossRefGoogle Scholar
  10. 10.
    Mbata G, Chukwuka J (2012) Obstructive sleep apnea hypopnea syndrome. Ann Med Health Sci Res 2:74–77. CrossRefGoogle Scholar
  11. 11.
    Oldenburg O, Arzt M, Bitter T et al (2015) Positionspapier „Schlafmedizin in der Kardiologie“. Kardiologe 9(140). CrossRefGoogle Scholar
  12. 12.
    Eckert DJ, Younes MK (2014) Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. J Appl Physiol (1985) 116:302–313. CrossRefGoogle Scholar
  13. 13.
    Quan SF (2012) Obstructive sleep apnea and cardiovascular disease: back and forward in time over the last 25 years. Southwest J Pulm Crit Care 5:206–217Google Scholar
  14. 14.
    Drager LF, McEvoy RD, Barbe F, Lorenzi-Filho G, Redline S, INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists) (2017) Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science. Circulation 136:1840–1850. CrossRefGoogle Scholar
  15. 15.
    Song D, Fang G, Greenberg H, Liu SF (2015) Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review. Immunol Res 63:121–130. CrossRefGoogle Scholar
  16. 16.
    Adedayo AM, Olafiranye O, Smith D, Hill A, Zizi F, Brown C et al (2014) Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath Schlaf Atm 18:13–18. CrossRefGoogle Scholar
  17. 17.
    Eisele H‑J, Markart P, Schulz R (2015) Obstructive sleep apnea, oxidative stress, and cardiovascular disease: evidence from human studies. Oxid Med Cell Longev 2015:608438. CrossRefGoogle Scholar
  18. 18.
    Xing T, Pilowsky PM (2010) Acute intermittent hypoxia in rat in vivo elicits a robust increase in tonic sympathetic nerve activity that is independent of respiratory drive. J Physiol 588:3075–3088. CrossRefGoogle Scholar
  19. 19.
    Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33:1467–1484. CrossRefGoogle Scholar
  20. 20.
    Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25. CrossRefGoogle Scholar
  21. 21.
    Lalande S, Luoma CE, Miller AD, Johnson BD (2012) Effect of changes in intrathoracic pressure on cardiac function at rest and during moderate exercise in health and heart failure. Exp Physiol 97:248–256. CrossRefGoogle Scholar
  22. 22.
    Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ et al (2014) Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 27:1293–1300. CrossRefGoogle Scholar
  23. 23.
    Amatoury J, Howitt L, Wheatley JR, Avolio AP, Amis TC (2006) Snoring-related energy transmission to the carotid artery in rabbits. J Appl Physiol Bethesda Md 1985 100:1547–1553. CrossRefGoogle Scholar
  24. 24.
    Lui MM-S, Sau-Man M (2012) OSA and atherosclerosis. J Thorac Dis 4:164–172. CrossRefGoogle Scholar
  25. 25.
    Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904. CrossRefGoogle Scholar
  26. 26.
    Castaneda A, Jauregui-Maldonado E, Ratnani I, Varon J, Surani S (2018) Correlation between metabolic syndrome and sleep apnea. World J Diabetes 9:66–71. CrossRefGoogle Scholar
  27. 27.
    Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A et al (2012) Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 307:2161–2168. CrossRefGoogle Scholar
  28. 28.
    Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A et al (2007) The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167:757–764. CrossRefGoogle Scholar
  29. 29.
    Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet Lond Engl 365:1046–1053. CrossRefGoogle Scholar
  30. 30.
    Spießhöfer J, Fox H, Lehmann R, Efken C, Heinrich J, Bitter T et al (2016) Heterogenous haemodynamic effects of adaptive servoventilation therapy in sleeping patients with heart failure and Cheyne-Stokes respiration compared to healthy volunteers. Heart Vessels 31:1117–1130. CrossRefGoogle Scholar
  31. 31.
    Oldenburg O, Bartsch S, Bitter T, Schmalgemeier H, Fischbach T, Westerheide N et al (2012) Hypotensive effects of positive airway pressure ventilation in heart failure patients with sleep-disordered breathing. Sleep Breath Schlaf Atm 16:753–757. CrossRefGoogle Scholar
  32. 32.
    Amin M (2016) Can continuous positive airway pressure reverse carotid artery atherosclerosis in obstructive sleep apnea? Egypt J Chest Dis Tuberc 65:765–769CrossRefGoogle Scholar
  33. 33.
    Chen L‑D, Lin L, Lin X‑J, Ou Y‑W, Wu Z, Ye Y‑M et al (2017) Effect of continuous positive airway pressure on carotid intima-media thickness in patients with obstructive sleep apnea: a meta-analysis. PLoS ONE 12:e184293. CrossRefGoogle Scholar
  34. 34.
    Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73CrossRefGoogle Scholar
  35. 35.
    Robinson GV, Langford BA, Smith DM, Stradling JR (2008) Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax 63:855–859. CrossRefGoogle Scholar
  36. 36.
    McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375:919–931. CrossRefGoogle Scholar
  37. 37.
    Iftikhar IH, Valentine CW, Bittencourt LRA, Cohen DL, Fedson AC, Gíslason T et al (2014) Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens 32:2341–2350. (discussion 2350)CrossRefGoogle Scholar
  38. 38.
    Torres G, Sánchez-de-la-Torre M, Barbé F (2015) Relationship between OSA and hypertension. Chest 148:824–832. CrossRefGoogle Scholar
  39. 39.
    Feldstein CA (2016) Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: a systematic review of randomized clinical trials. Clin Exp Hypertens N Y N 1993 38:337–346. CrossRefGoogle Scholar
  40. 40.
    Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM (2012) Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 156:115–122. CrossRefGoogle Scholar
  41. 41.
    Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A (2007) Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 50:1310–1314. CrossRefGoogle Scholar
  42. 42.
    Doherty LS, Kiely JL, Swan V, McNicholas WT (2005) Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127:2076–2084. CrossRefGoogle Scholar
  43. 43.
    Milleron O, Pillière R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G et al (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25:728–734. CrossRefGoogle Scholar
  44. 44.
    Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E (2016) Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with Nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med 194:613–620. CrossRefGoogle Scholar
  45. 45.
    Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V et al (2017) Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA 318:156–166. CrossRefGoogle Scholar
  46. 46.
    Esquinas C, Sánchez-de-la Torre M, Aldomá A, Florés M, Martínez M, Barceló A et al (2013) Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: the ISAACC Trial. Clin Cardiol 36:495–501. CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Internal Medicine II—Cardiology/PneumologyUniversity of BonnBonnGermany

Personalised recommendations